ID   GK2
AC   CVCL_WH04
DR   cancercelllines; CVCL_WH04
DR   IARC_TP53; 13989
DR   Wikidata; Q93561536
RX   PubMed=9723033;
RX   PubMed=10841287;
CC   Doubling time: ~48 hours (PubMed=9723033).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=10841287).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 7
//
RX   PubMed=9723033; DOI=10.1016/S0165-4608(98)00023-5;
RA   Bertoni L., Zoli W., Mucciolo E., Ricotti L., Nergadze S., Amadori D.,
RA   Giulotto E.;
RT   "Different genome organization in two new cell lines established from
RT   human gastric carcinoma.";
RL   Cancer Genet. Cytogenet. 105:152-159(1998).
//
RX   PubMed=10841287;
RA   Calistri D., Barzanti F., Dal Susino M., Fedriga R., Saragoni L.,
RA   Bernardi L., Ricotti L., Zoli W.;
RT   "Correlation between p53 gene mutations and p53 protein accumulation
RT   evaluated by different methodologies.";
RL   J. Biol. Regul. Homeost. Agents 14:120-127(2000).
//